Skip to main content
OpenTrials

Clinical trial condition

Unspecified Childhood Solid Tumor, Protocol Specific

Explore clinical trials studying Unspecified Childhood Solid Tumor, Protocol Specific. Study availability and eligibility vary by location and protocol.

100 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Unspecified Childhood Solid Tumor, Protocol Specific trial results

Completed

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

NCT00674193

Conditions
Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma, +44 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Miller Children's Hospital Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Childrens Hospital of Orange County Orange, California, United States
View all 38 locations
View Trial Details
Completed

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

NCT00458887

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, +7 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Southern California Permanente Medical Group Los Angeles, California, United States
View all 81 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

NCT00018967

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +4 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 103 locations
View Trial Details

Related conditions